ES8606870A1 - Procedimiento para la preparacion de 1,3-bis-esteres fosfatode 9-1,3-dihidroxi-2-propoximetil-guanina - Google Patents

Procedimiento para la preparacion de 1,3-bis-esteres fosfatode 9-1,3-dihidroxi-2-propoximetil-guanina

Info

Publication number
ES8606870A1
ES8606870A1 ES542298A ES542298A ES8606870A1 ES 8606870 A1 ES8606870 A1 ES 8606870A1 ES 542298 A ES542298 A ES 542298A ES 542298 A ES542298 A ES 542298A ES 8606870 A1 ES8606870 A1 ES 8606870A1
Authority
ES
Spain
Prior art keywords
esters
propoxymethyl
guanine
dihydroxy
bisphosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542298A
Other languages
English (en)
Other versions
ES542298A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES8606870A1 publication Critical patent/ES8606870A1/es
Publication of ES542298A0 publication Critical patent/ES542298A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1745—Unsaturated ethers containing halogen containing six-membered aromatic rings having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 1,3-BIS-ESTERES FOSFATO DE 9-(1,3-DIHIDROXI-2-PROPORXIMETIL)-GUANINA, DE FORMULA (I), EN LA QUE W Y WA SON RADICALES DE FORMULA (II), DONDE B ES HIDROGENO O UN ION ANTAGONISTA FISIOLOGICAMENTE COMPATIBLE; Y X VALE 1 O 2. COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA (II), EN LA QUE M REPRESENTA EL GRUPO 4-MORFOLINO, CON EL COMPUESTO APROPIADO DE FOSFATO DE TRIBUTILAMONIO TAL QUE SE FORME UN COMPUESTO DE FORMULA (I), EN LA QUE W, WA, B Y X TENGAN EL SIGNIFICADO INDICADO ANTERIORMENTE. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE INFECCIONES VIRICAS.
ES542298A 1982-09-30 1985-04-16 Procedimiento para la preparacion de 1,3-bis-esteres fosfatode 9-1,3-dihidroxi-2-propoximetil-guanina Expired ES8606870A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43193382A 1982-09-30 1982-09-30
US46427483A 1983-02-07 1983-02-07

Publications (2)

Publication Number Publication Date
ES8606870A1 true ES8606870A1 (es) 1986-05-16
ES542298A0 ES542298A0 (es) 1986-05-16

Family

ID=27029273

Family Applications (4)

Application Number Title Priority Date Filing Date
ES526064A Granted ES526064A0 (es) 1982-09-30 1983-09-29 Procedimiento para la preparacion de 1-esteres monofosfato, 1,3-bis-esteres fosfato y esteres fosfato ciclico de 9-(1,3-dihidroxi-2-propoximetil)-guanina
ES542298A Expired ES8606870A1 (es) 1982-09-30 1985-04-16 Procedimiento para la preparacion de 1,3-bis-esteres fosfatode 9-1,3-dihidroxi-2-propoximetil-guanina
ES542299A Expired ES8605520A1 (es) 1982-09-30 1985-04-16 Procedimiento para la preparacion de 1,3-bis-esteres fosfatoy esteres fosfato ciclico de 9-1,3-dihidroxi-2-propoximetil-guanina
ES542297A Expired ES8605533A1 (es) 1982-09-30 1985-04-16 Procedimiento para la preparacion de esteres fosfato ciclicode 9-1,3-dihidroxi-2-propoximetil-guanina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES526064A Granted ES526064A0 (es) 1982-09-30 1983-09-29 Procedimiento para la preparacion de 1-esteres monofosfato, 1,3-bis-esteres fosfato y esteres fosfato ciclico de 9-(1,3-dihidroxi-2-propoximetil)-guanina

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES542299A Expired ES8605520A1 (es) 1982-09-30 1985-04-16 Procedimiento para la preparacion de 1,3-bis-esteres fosfatoy esteres fosfato ciclico de 9-1,3-dihidroxi-2-propoximetil-guanina
ES542297A Expired ES8605533A1 (es) 1982-09-30 1985-04-16 Procedimiento para la preparacion de esteres fosfato ciclicode 9-1,3-dihidroxi-2-propoximetil-guanina

Country Status (7)

Country Link
EP (1) EP0105486A3 (es)
AU (1) AU565012B2 (es)
DK (1) DK448983A (es)
ES (4) ES526064A0 (es)
FI (1) FI833504A (es)
NO (1) NO833526L (es)
NZ (1) NZ205802A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
EP0138683A3 (en) * 1983-09-30 1988-01-20 Merck & Co. Inc. Purine derivatives, their application in anti-viral compositions
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
CA1330794C (en) * 1987-03-27 1994-07-19 Phillip Frost Anti-viral compounds, dosage forms and methods
CN108794477A (zh) * 2018-08-06 2018-11-13 华东师范大学 一种n2取代鸟嘌呤类化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation

Also Published As

Publication number Publication date
ES542297A0 (es) 1986-04-01
FI833504A (fi) 1984-03-31
NO833526L (no) 1984-04-02
AU1972383A (en) 1984-04-05
NZ205802A (en) 1986-10-08
AU565012B2 (en) 1987-09-03
DK448983A (da) 1984-03-31
ES8507550A1 (es) 1985-09-16
EP0105486A2 (en) 1984-04-18
ES542299A0 (es) 1986-04-01
ES8605520A1 (es) 1986-04-01
EP0105486A3 (en) 1984-05-16
ES8605533A1 (es) 1986-04-01
ES542298A0 (es) 1986-05-16
FI833504A0 (fi) 1983-09-29
ES526064A0 (es) 1985-09-16
DK448983D0 (da) 1983-09-29

Similar Documents

Publication Publication Date Title
ES8701496A1 (es) Procedimiento para preparar una sal de 9-(1, 3-dihidroxi-2-propoximetil)-guanina farmaceuticamente aceptable
AU1261488A (en) Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
EP0506892A4 (en) Boronated nucleosides
IL79700A (en) Antiviral compositions containing 2',3'-dideoxyinosine,2',3'-dideoxyguanosine or 2',3'-dideoxyadenosine or phosphates thereof and their use in a method for alleviating the cytopathic effects of htlv-iii virus on cells in vitro
DE3163982D1 (en) Topical formulations of 9-(2-hydroxyethoxymethyl) guanine
ES8605533A1 (es) Procedimiento para la preparacion de esteres fosfato ciclicode 9-1,3-dihidroxi-2-propoximetil-guanina
IE831386L (en) Pharmaceutical compositions based on xylosides and lyxosides¹of purine and pyrimidine bases
ES8600763A1 (es) Procedimiento de preparacion de nuevos derivados de guarnina.
ZA837287B (en) 1-monophosphate esters,1,3-bisphosphate esters and cyclic phosphate esters of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as antiviral agents
NZ186555A (en) 9-(2-hydroxyethoxymethyl)-guanine monophosphate
AU87768S (en) Vehicle tire
AU87767S (en) Vehicle tire
KE3561A (en) Topical formulations of 9-(2-hydroxyethoxymethyl)guanine
ZA83626B (en) Substituted 9-(1 or 3-monoacyloxy or 1, 3-diacyloxy-2-propoxy-methyl purines as antiviral agent
UA7932A1 (uk) 1,4-піперазинбіс(етиленаміддиетиленімінотіофосфорної кислоти), що виявляє протипухлинну та противірусну дію
JPS5356691A (en) Production of 99*betaadd arabinofuracil* adenine 5** phosphate
ZA888892B (en) 9-(2-phosphonomethoxy)ethoxy)-purines
BG34745A1 (en) Power amplifier of class bc
GR871303B (en) 9-(2-hydroxy- ethoxy-methyl) guanine or acyclovir
ZA833947B (en) Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl)guanine
JO936B1 (en) Making phosphate for solid shader

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971103